Literature DB >> 7420120

Sympathetic reflex latencies and conduction velocities in patients with polyneuropathy.

J Fagius, B G Wallin.   

Abstract

(1) Micro-electrode recordings of multi-unit sympathetic activity were attempted in skin or muscle branches of the peroneal nerve at the fibular head and the median nerve at the elbow in 41 patients with polyneuropathy of different causes. An indirect measure of sympathetic conduction velocity was obtained by determining the latency of either of two sympathetic reflexes. For skin nerve sympathetic activity (SSA) reflex responses to electrical skin stimuli were used and for muscle nerve sympathetic activity (MSA) reflex inhibition caused by the arterial pulse wave. The skin sympathetic function was also evaluated by measuring changes in skin resistance and finger/toe pulse plethysmograms. Motor conduction velocities were measured with surface electrodes. (2) In muscle (but not in skin) nerve fascicles afferent mass activity in myelinated fibres was often weak or absent. (3) There was a significant relationship between symptoms of autonomic impairment and impaired skin resistance and/or plethysmographic responses. There was also a relationship between impairment of these responses and failure to detect SSA. (4) Failure to find sympathetic activity occurred in 60% of diabetic patients but only in 27% of the whole material. When found, sympathetic activity had normal appearance and sympathetic reflex latencies were normal irrespective of degree of slowing of motor conduction velocity. (5) The results suggest that in polyneuropathy conduction velocities of post-ganglionic sympathetic fibres are normal as long as the fibres conduct. Degeneration of sympathetic fibres may be especially common in diabetic neuropathy.

Entities:  

Mesh:

Year:  1980        PMID: 7420120     DOI: 10.1016/0022-510x(80)90099-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  A comparison of peripheral vasoconstrictor responses and cardiovascular autonomic function tests in diabetic patients.

Authors:  J E Gilmore; J A Allen; J R Hayes
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

2.  Quantitation of skin vasomotor control in normal subjects and in diabetic patients with autonomic neuropathy.

Authors:  A F Donk; T J Faes; D Broere; E A van der Veen; F W Bertelsmann
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

3.  Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients.

Authors:  D L Eckberg; S W Harkins; J M Fritsch; G E Musgrave; D F Gardner
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies.

Authors:  B T Shahani; J J Halperin; P Boulu; J Cohen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

5.  Microneurographic findings in diabetic polyneuropathy with special reference to sympathetic nerve activity.

Authors:  J Fagius
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

6.  Acute pandysautonomia and severe sensory deficit with poor recovery. A clinical, neurophysiological and pathological case study.

Authors:  J Fagius; C E Westerberg; Y Olsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-08       Impact factor: 10.154

7.  The validity and reproducibility of the skin vasomotor test--studies in normal subjects, after spinal anaesthesia, and in diabetes mellitus.

Authors:  T J Faes; M F Wagemans; J M Cillekens; G J Scheffer; J M Karemaker; F W Bertelsmann
Journal:  Clin Auton Res       Date:  1993-10       Impact factor: 4.435

8.  Sweat function in Parkinson's disease.

Authors:  Y Mano; T Nakamuro; T Takayanagi; R F Mayer
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

9.  Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

Authors:  J Fagius; S Jameson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-11       Impact factor: 10.154

10.  Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.

Authors:  J Fagius; A Brattberg; S Jameson; C Berne
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.